BLCO Stock Summary and Trading Ideas (Bausch & Lomb | NYSE:BLCO)

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb trades on the NYSE stock market under the symbol BLCO.

As of March 5, 2025, BLCO stock price declined to $15.70 with 565,332 million shares trading.

BLCO has a beta of 0.52, meaning it tends to be less sensitive to market movements. BLCO has a correlation of 0.03 to the broad based SPY ETF.

BLCO has a market cap of $5.53 billion. This is considered a Mid Cap stock.

Last quarter Bausch & Lomb reported $1 billion in Revenue and $.25 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.01.

The top ETF exchange traded funds that BLCO belongs to (by Net Assets): MGMT, IPO, CZA, DFIC, DFAX.

BLCO has underperformed the market in the last year with a return of -5.1%, while the SPY ETF gained +15.2%. In the last 3 month period, BLCO fell short of the market, returning -20.5%, while SPY returned -3.7%. However, in the most recent 2 weeks BLCO has outperformed the stock market by returning -4.0%, while SPY returned -4.6%.

BLCO support price is $15.53 and resistance is $16.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLCO shares will trade within this expected range on the day.